Sulfadiazine: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* Antimicrobial that inhibits dihydrofolic acid synthesis * Indications include Is treatment for::toxoplasmosis, Is treatment for::malaria, and Is treatment for::Noc..." |
(No difference)
|
Revision as of 14:15, 19 September 2019
- Antimicrobial that inhibits dihydrofolic acid synthesis
- Indications include toxoplasmosis, malaria, and Nocardia
- Adverse events include
- GI intolerance
- Pruritic rash
- Bone marrow suppression of any line
- Serum sickness and drug fever
- Crystal-induced nephropathy
- Photosensitivity
- Hepatitis
